Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interpretable Multimodal Model Based on Cytology Ultrasound Noninvasively Predicts Lymph Node Metastasis in cN0 Papillary Thyroid Cancer

NCT06399159 is registered in ClinicalTrials.gov with Nanchong Central Hospital as lead sponsor.

NCT NCT06399159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06399159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interpretable Multimodal Model Based on Cytology Ultrasound Noninvasively Predicts Lymph Node Metastasis in cN0 Papillary Thyroid Cancer
Lead sponsor
Nanchong Central Hospital
Phase
Observational
Overall status
Completed
Start date
September 1, 2023
Completion date
April 1, 2024
Enrollment
1,500 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymph node metastasis, papillary thyroid carcinoma